Ticker

JPMorgan Chase is rated a Buy for its fortress balance sheet, superior ROTCE, and proven resilience through economic downturns. JPM's ROTCE reached 24% for the first nine months of FY26, with a CET1 ratio of 13.9%, well above regulatory requirements. Despite a premium valuation (P/TBVPS > 3.0x, forward P/E 13.8x), I believe JPM's capital efficiency, liquidity, and growth justify the price.

JPMorgan Chase has deployed $5 billion into startup investments in the first year of its U.S. security and resiliency initiative, halfway to its initial $10 billion goal. The bank may exceed that target, co-president Doug Petno told CNBC.

In a rare occurrence, JPMorgan Chase's Q3 revenue and earnings per share missed analyst estimates. The company raised full-year guidance for net interest income.

JPMorgan Chase remains a strong buy despite worsening macroeconomic indicators and potential cyclical downturns. I prioritize JPM's exceptional management, led by Jamie Dimon, as the key differentiator and primary reason for continued investment. JPM consistently delivers return on common equity of 17% to 24%, well above the typical long-term average of 13%.

JPMorgan Chase & Co. missed Q3 earnings and revenue expectations, prompting a downgrade to hold for the next quarter. Robust loan growth of 2.8% in Q3 and 10.6% YoY supported net interest income, while deposit growth remained strong at over 9% YoY. Elevated external financing above $1.2 trillion and rising short-term rates pose risks, increasing interest expense and pressuring investment banking returns.